Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.03 | N/A |
| PEG Ratio (TTM) | -4.84 | N/A |
| P/S Ratio (TTM) | 1.25 | N/A |
| P/B Ratio (TTM) | 2.23 | N/A |
| P/FCF Ratio (TTM) | -139.32 | N/A |
| Price to 5YR AVG Earnings Ratio | 32.07 | N/A |
| Price to 5YR AVG FCF Ratio | 66.38 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.00% | N/A |
| ROE (TTM) | 8.21% | N/A |
| Net Profit Margin (TTM) | 4.45% | N/A |
| ROIC 5YR AVG | 8.47% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.04% | 150.16% | 95.85% |
| Revenue | 2.26% | 8.60% | 7.38% |
| Net Income | 0.31% | 147.42% | 94.44% |
| Cash Flow | 94.35% | 7.02% | 14.82% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.15 | N/A |
| Quick Ratio (TTM) | 1.26 | N/A |
| D/E Ratio (TTM) | 0.53 | N/A |
| Interest Coverage (TTM) | 2.88 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.50 | N/A |
| LTL to 5YR AVG FCF | 14.52 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.40% | N/A |